Iridian Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.22M | Sell |
|
|||||
|
2025
Q1 | $9.09M | Buy |
|
|||||
|
2024
Q4 | $9.41M | Sell |
|
|||||
|
2024
Q3 | $10.8M | Buy |
|
|||||
|
2024
Q2 | $9.54M | Buy |
|
|||||
|
2024
Q1 | $6.61M | Sell |
|
|||||
|
2023
Q4 | $7.36M | Buy |
|
|||||
|
2023
Q3 | $5.75M | Sell |
|
|||||
|
2023
Q2 | $14.2M | Buy |
|
|||||
|
2023
Q1 | $13.3M | Sell |
|
|||||
|
2022
Q4 | $17.1M | Sell |
|
|||||
|
2022
Q3 | $17.3M | Sell |
|
|||||
|
2022
Q2 | $19.8M | Buy |
|
|||||
|
2022
Q1 | $21.2M | Buy |
|
|||||
|
2021
Q4 | $22M | Sell |
|
|||||
|
2021
Q3 | $45.7M | Sell |
|
|||||
|
2021
Q2 | $76.3M | Sell |
|
|||||
|
2021
Q1 | $69.8M | Sell |
|
|||||
|
2020
Q4 | $70.1M | Sell |
|
|||||
|
2020
Q3 | $73.2M | Sell |
|
|||||
|
2020
Q2 | $76.2M | Sell |
|
|||||
|
2020
Q1 | $60.2M | Buy |
|
|||||
|
2019
Q4 | $32.2M | Buy |
|